Photo: The Tribune
Zydus Cadila: Only Needle-Free COVID Vaccine Gets Emergency Use Approval
Vaccine maker Zydus Cadila's needle-free three-dose Covid-19 vaccine finally got approval for emergency use in India by the Indian drug regulator's subject committee expert. The Ahmedabad-based company had applied for the approval of its vaccine ZyCoV-D, on July 1. Reportedly, the vaccine can be given to adults and children above 12 years of age for the first time in India. Zydus is planning on making over 100 million doses yearly.
Tags: Zydus Cadila, Covid Vaccination, DGCI, Indian drug manufacturer
Courtesy: NDTV
Photo: News Nation
DGCI Approves Research On Mixing Two Covid Vaccines
The Drugs Controller General of India (DCGI) on August 10 gave permission for conducting a study on the mixing of doses of Covaxin and Covishield vaccines against the Covid-19 virus. It advised that the research and trials will be done by Christian College in Vellore. The Indian Council for Medical Research (ICMR) in its previous study disclosed that combining the two vaccines has shown "better immunogenicity."
Tags: Covid-19, COVISHIELD, Covaxin, DGCI, ICMR Research
Courtesy: The Times of India
